SCHEMBL6463706

SCHEMBL6463706

CC(c1ccc(C(F)(F)F)cc1)[C@H]1CNCCN1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 3/20 0.40
SLC6A3 Q01959 1/20 0.40
HTR2C P28335 6/20 0.38
HTR2A P28223 4/20 0.38
HTR2B P41595 4/20 0.38
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
PAX8 Q06710 1/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PDE2A O00408 1/20 0.36
TEAD1 P28347 1/20 0.35
HSD11B1 P28845 2/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6447627 0.83 SLC6A4 (0.43) SLC6A2SLC6A4SLC6A3HTR2CHTR2A
SCHEMBL1638129 0.72 HTR2C (0.51) HTR2CHTR2AHTR2B
SCHEMBL6504554 0.71 SLC6A2 (0.35) SLC6A2SLC6A4SLC6A3
SCHEMBL5144723 0.71 SLC6A4 (0.42) SLC6A2SLC6A4HTR2CHTR2AHTR2B
SCHEMBL10327140 0.70 MEN1 (0.47) SLC6A2SLC6A4SLC6A3HTR2CMEN1
SCHEMBL2839315 0.70 MEN1 (0.47) SLC6A2SLC6A4SLC6A3HTR2CMEN1
SCHEMBL27960267 0.69
SCHEMBL8534452 0.69 SLC6A4 (0.49) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
SCHEMBL13169223 0.69 CCR5 (0.45) HTR2CHTR2AHTR2BTEAD1
SCHEMBL12954773 0.69 CCR5 (0.45) HTR2CHTR2AHTR2BTEAD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492794-A1 PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS ELI LILLY AND COMPANY (US) 2005-01-05 EP disclosed
WO-2003082877-A1 PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS ELI LILLY AND COMPANY (US) 2003-10-09 WO disclosed